Enjamb Labs

Enjamb Labs builds an AI-agent platform for pharmaceutical drug development. Its browser-based "integrated research environment" runs specialized agents across the full R&D lifecycle -- clinical evidence synthesis, trial design and statistical programming, and regulatory submission preparation -- while connecting to the systems pharma teams already use (Benchling, Veeva, Medidata, SAS) so no data migration is required. The workspace bundles Word/Excel/PowerPoint editors, Python and R compute environments, and 100+ scientific integrations, and emphasizes auditability, traceability, and human review, keeping each output attached to its sources, files, code, and decisions. Backed by Y Combinator and Founders, Inc., Enjamb reports early usage across major pharmaceutical companies including Johnson & Johnson, Merck, AbbVie, Bristol Myers Squibb, and Sanofi.

Enjamb Labs is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, AI Agents, Pharmaceutical, and Drug Development.

Enjamb Labs’ developer surface includes engineering blog, pricing, signup flow, and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

18.3/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyArtificial IntelligenceAI AgentsPharmaceuticalDrug DevelopmentClinical ResearchRegulatoryLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 18.3/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 8.9 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/enjamb-labs: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Get Started 2

Portal, sign-up, and the first successful call

SignUp

SignUp

Login

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 3

Pricing, plans, and the legal terms of use

Pricing

Pricing

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 4

The organization behind the API

Website

Website

Blog

Blog

About

About

LinkedIn

Source (apis.yml)

aid: enjamb-labs
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/enjamb-labs.png
name: Enjamb Labs
description: Enjamb Labs builds an AI-agent platform for pharmaceutical drug development. Its browser-based "integrated research
  environment" runs specialized agents across the full R&D lifecycle -- clinical evidence synthesis, trial design and statistical
  programming, and regulatory submission preparation -- while connecting to the systems pharma teams already use (Benchling,
  Veeva, Medidata, SAS) so no data migration is required. The workspace bundles Word/Excel/PowerPoint editors, Python and
  R compute environments, and 100+ scientific integrations, and emphasizes auditability, traceability, and human review, keeping
  each output attached to its sources, files, code, and decisions. Backed by Y Combinator and Founders, Inc., Enjamb reports
  early usage across major pharmaceutical companies including Johnson & Johnson, Merck, AbbVie, Bristol Myers Squibb, and
  Sanofi.
url: https://raw.githubusercontent.com/api-evangelist/enjamb-labs/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
- founders-inc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Artificial Intelligence
- AI Agents
- Pharmaceutical
- Drug Development
- Clinical Research
- Regulatory
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.enjamb.ai
- type: Blog
  url: https://www.enjamb.ai/blog
- type: Pricing
  url: https://www.enjamb.ai/pricing
- type: SignUp
  url: https://app.enjamb.ai
- type: Login
  url: https://app.enjamb.ai
- type: TermsOfService
  url: https://www.enjamb.ai/terms-of-service
- type: PrivacyPolicy
  url: https://www.enjamb.ai/privacy-policy
- type: About
  url: https://www.enjamb.ai/about
- type: LinkedIn
  url: https://www.linkedin.com/company/enjamb/
- type: DomainSecurity
  url: security/enjamb-labs-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence